 | • レポートコード：TPM-C02048 • 出版社/出版日：Transparency Market Research / 2019年1月25日 • レポート形態：英文、PDF、165ページ • 納品方法：Eメール • 産業分類：Healthcare |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、乳房再建術の世界市場について調べ、乳房再建術の世界規模、市場動向、市場環境、製品別（乳房インプラント、組織エキスパンダー、無細胞皮膚マトリックス（ADM））分析、エンドユーザー別（病院、外来手術センター）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・乳房再建術の世界市場動向 ・乳房再建術の世界市場環境 ・乳房再建術の世界市場規模 ・乳房再建術の世界市場規模：製品別（乳房インプラント、組織エキスパンダー、無細胞皮膚マトリックス（ADM）） ・乳房再建術の世界市場規模：エンドユーザー別（病院、外来手術センター） ・乳房再建術の世界市場：地域別市場規模・分析 ・乳房再建術の北米市場規模・予測 ・乳房再建術のアメリカ市場規模・予測 ・乳房再建術の中南米市場規模・予測 ・乳房再建術のヨーロッパ市場規模・予測 ・乳房再建術のアジア市場規模・予測 ・乳房再建術の日本市場規模・予測 ・乳房再建術の中国市場規模・予測 ・乳房再建術のインド市場規模・予測 ・乳房再建術の中東市場規模・予測 ・乳房再建術のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Breast Reconstruction Market: Overview
This report analyzes the current and future scenario of the global breast reconstruction market. Growth of the market is attributed to rise in prevalence of breast cancer, surge in demand for breast implants & acellular dermal matrix, and increase in focus on research and development activities. Additionally, rise in focus on women’ health and increase in awareness about breast reconstruction after mastectomy fuel the growth of the global breast reconstruction market. According to Breastcancer.org, in the U.S., nearly 1 in 8 women develop invasive breast cancer, accounting to about 12.4% of cases of breast cancer globally. Moreover, breast cancer is a common type of cancer diagnosed among women in the U.S. However, product recalls by regulatory authorities and complications due to breast implants & other products are expected to hamper the growth of the global market.
The global breast reconstruction market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global breast reconstruction market.
Global Breast Reconstruction Market: Key Segments
In terms of product, the global breast reconstruction market has been classified into breast implants, tissue expanders, acellular dermal matrix (ADM), and others. The acellular dermal matrix segment is projected to expand at the fastest CAGR during the forecast period. Large number of manufacturers focusing on development of dermal matrices for indications such as breast reconstruction and hernia repair is a major factor propelling the segment. Usage of acellular dermal matrix in breast reconstruction by plastic surgeons has increased, especially in the developed countries such as the U.S. Based on end-user, the global market has been divided into hospitals and ambulatory surgical centers. The ambulatory surgical centers segment is anticipated to experience significant growth in terms of revenue and market share during the forecast period. The segments have been analyzed based on available products used during breast reconstruction surgeries for the treatment of any breast deformities, improve esthetic appearance, and reconstruction of breast after mastectomy. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026 along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Breast Reconstruction Market: Regional Outlook
In terms of region, the global breast reconstruction market has been segmented into five major regions: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026 along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report profiles major players in the global breast reconstruction market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Players profiled in the report include Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe.
The global breast reconstruction market has been segmented as below:
Global Breast Reconstruction Market, by Product
Breast Implants
Tissue Expanders
Acellular Dermal Matrix (ADM)
Others
Global Breast Reconstruction Market, by End-user
Hospitals
Ambulatory Surgical Centers
Global Breast Reconstruction Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Breast Reconstruction Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Breast Reconstruction Market Analysis and Forecast, 2016–2026
5. Key Insights
5.1. New Product Launch and Regulatory Approvals
5.2. Novel Technology in Breast Reconstruction
6. Global Breast Reconstruction Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Breast Implants
6.3.1.1. Silicone
6.3.1.2. Saline
6.3.2. Tissue Expanders
6.3.3. Acellular Dermal Matrix (ADM)
6.4. Market Attractiveness, by Product
7. Global Breast Reconstruction Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2016–2026
7.3.1. Hospitals
7.3.2. Ambulatory Care Centers
7.4. Market Attractiveness, by End-user
8. Global Breast Reconstruction Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Breast Reconstruction Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2016–2026
9.2.1. Breast Implants
9.2.1.1. Silicone
9.2.1.2. Saline
9.2.2. Tissue Expanders
9.2.3. Acellular Dermal Matrix (ADM)
9.3. Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals
9.3.2. Ambulatory Care Centers
9.4. Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Breast Reconstruction Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product , 2016–2026
10.2.1. Breast Implants
10.2.1.1. Silicone
10.2.1.2. Saline
10.2.2. Tissue Expanders
10.2.3. Acellular Dermal Matrix (ADM)
10.3. Market Value Forecast, by End-user, 2016–2026
10.3.1. Hospitals
10.3.2. Ambulatory Care Centers
10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Breast Reconstruction Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2016–2026
11.2.1. Breast Implants
11.2.1.1. Silicone
11.2.1.2. Saline
11.2.2. Tissue Expanders
11.2.3. Acellular Dermal Matrix (ADM)
11.3. Market Value Forecast, by End-user, 2016–2026
11.3.1. Hospitals
11.3.2. Ambulatory Care Centers
11.4. Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Breast Reconstruction Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2016–2026
12.2.1. Breast Implants
12.2.1.1. Silicone
12.2.1.2. Saline
12.2.2. Tissue Expanders
12.2.3. Acellular Dermal Matrix (ADM)
12.3. Market Value Forecast, by End-user, 2016–2026
12.3.1. Hospitals
12.3.2. Ambulatory Care Centers
12.4. Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Breast Reconstruction Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2016–2026
13.2.1. Breast Implants
13.2.1.1. Silicone
13.2.1.2. Saline
13.2.2. Tissue Expanders
13.2.3. Acellular Dermal Matrix (ADM)
13.3. Market Value Forecast, by End-user, 2016–2026
13.3.1. Hospitals
13.3.2. Ambulatory Care Centers
13.4. Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Share Analysis, by Company (2017)
14.2. Company Profiles
14.2.1. Allergan
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Financial Overview
14.2.1.3. Product Portfolio
14.2.1.4. SWOT Analysis
14.2.1.5. Strategic Overview
14.2.2. Mentor Worldwide LLC (Johnson & Johnson)
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Financial Overview
14.2.2.3. Product Portfolio
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Sientra, Inc.
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Financial Overview
14.2.3.3. Product Portfolio
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Establishment Labs S.A.
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Financial Overview
14.2.4.3. Product Portfolio
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. POLYTECH Health & Aesthetics GmbH
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Financial Overview
14.2.5.3. Product Portfolio
14.2.5.4. SWOT Analysis
14.2.5.5. Strategic Overview
14.2.6. RTI Surgical, Inc.
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Financial Overview
14.2.6.3. Product Portfolio
14.2.6.4. SWOT Analysis
14.2.6.5. Strategic Overview
14.2.7. Groupe Sebbin SAS
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Financial Overview
14.2.7.3. Product Portfolio
14.2.7.4. SWOT Analysis
14.2.7.5. Strategic Overview
14.2.8. Integra LifeSciences
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Financial Overview
14.2.8.3. Product Portfolio
14.2.8.4. SWOT Analysis
14.2.8.5. Strategic Overview
14.2.9. Wanhe
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Financial Overview
14.2.9.3. Product Portfolio
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. GC Aesthetics
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Financial Overview
14.2.10.3. Product Portfolio
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
Table 01: Product Launch and Regulatory Approvals in Breast Reconstruction Market, by Company
Table 02: Product Launch and Regulatory Approvals in Breast Reconstruction Market, by Company
Table 03: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 04: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Breast Implants, 2016–2026
Table 05: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 06: Global Breast Reconstruction Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 07: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 08: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 09: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2016–2026
Table 10: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2016–2026
Table 14: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 17: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2016–2026
Table 18: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 21: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2016–2026
Table 22: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 23: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 24: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 25: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2016–2026
Table 26: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2016–2026